I prefer to look at macro on this to understand the general trends in this sector: Cancer Immunotherapy.
I am an amateur, however I think that the correlation is strong, and simple for anyone to see:
Comparison of CHM (green/red candles) against NYSEARCA:IDNA (purple) & NASDAQ:CNCR (blue).
IDNA and CNCR are immunotherapy ETFs.
Threw Hopper's other immunotherapy listing in there also: ASX:IMU (orange).
ASX:XHJ (white) indicates sector rotation out of healthcare.
Bull bear trend (bottom) describes CHM's moderately bearish few months, following positive sentiment after November's price sensitive results.
The pandemic has greatly impacted medical research, due to shortage of supply, workers and extra regulations at hospitals. In hindsight, the past few years may have been the wrong time to invest in biotec stocks. Especially those whose goals take time to realize, as clinical trials have been slowed and therefore extended in duration. IMO
CHM Price at posting:
21.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)